Chancellor Rachel Reeves Aims for Focused Action on Living Costs in Forthcoming Budget

Chancellor Reeves has stated she is planning "specific action to address cost of living issues" in next month's financial statement.

In comments to media outlets, she emphasized that reducing inflation is a collective duty of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the G7 advanced economies this year and the following year.

Possible Energy Cost Interventions

It is understood the administration could intervene to reduce energy bills, for instance by reducing the current 5% rate of VAT charged on energy supplies.

A further possibility is to cut some of the policy costs presently included in bills.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for these measures.

The expectation from most experts is that Reeves will have to announce tax increases or budget cuts in order to fulfill her self-imposed debt limits.

Previously on the same day, estimates showed there was a twenty-two billion pound shortfall for the chancellor to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the sources of price increases," the Chancellor told the BBC in Washington, at the conferences of the IMF and World Bank.

Tax Commitments and Global Concerns

While much of the attention has been on expected tax rises, the Treasury chief said the latest figures from the OBR had not changed her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She blamed an "unpredictable world" with increasing international and trade concerns for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."

International Trade Tensions

Referring to apprehensions about the United Kingdom's economic relations with China she said: "Our national security invariably come first."

Recent announcement by Chinese authorities to strengthen export controls on critical minerals and other resources that are key for high-technology production led US President Donald Trump to suggest an extra 100% import tax on imports from the Asian country, raising the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to join its dispute with China, Reeves said she was "deeply worried" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the global economy and causes additional obstacles."

"It is my opinion there are fields where we must challenge China, but there are also significant opportunities to trade with China's economy, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources approach, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also recognized that the cost the National Health Service spends on medicines could rise as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and investment.

Some of the world's largest drug companies have said in recent statements that they are either halting or abandoning operations in the UK, with several attributing the modest returns they are obtaining.

Recently, the government science advisor said the price the NHS pays for medicines would need to rise to stop businesses and drug research funding leaving the UK.

Reeves stated to the BBC: "It has been observed as a result of the pricing regime, that medical research, new drugs have not been available in the UK in the way that they are in other EU nations."

"The objective is to make sure that people getting care from the NHS are can obtain the best critical treatments in the world. And so we are examining all of that, and... looking to obtain additional funding into Britain."